The Millennium Preclinical Drug Compound Request program facilitates investigator initiated oncology related research. Millennium: The Takeda Oncology Company is willing to assist investigators by providing certain research and marketed compounds for eligible pre-clinical studies.

How does this work?

Investigators will enter their contact information and a detailed study proposal step by step in the Millennium Preclinical Drug Compound Request program. When completed, investigators submit research study proposals to Millennium. Millennium research or development teams will review each proposal, and if the study is approved, a material transfer agreement will be negotiated with your institution.

How long will it take?

Typically, the review process can take 4 to 8 weeks from the time Millennium receives your proposal. The contract negotiation phase varies widely, depending on the institution.

What is the application process?

Before you enter the Millennium Preclinical Drug Compound Request System, you will be asked to create a username and password. Once in the system, you will provide your contact information, names of any collaborators, and lab interests. In step 2, you will enter the overall goal of your study, and each specific aim, along with information on the methods and materials (e.g. cell lines, models) you will use. You will be asked to upload your cv. Please save your work as you go. You can return to your application at any time. When completed, you simply click the "submit" button and Millennium will begin the review process. You may track the status of your request by logging back into the Millennium Preclinical Drug Compound Request System at any time. You will be notified by email as to the review committee's decision. The investigator will be responsible for:

  • Disclosing other relevant third party affiliations (collaborators, compounds, cell lines, models)
  • Submitting twice yearly data/status updates
  • Informing Millennium of any study related milestones or events
  • Informing Millennium if you change institutions
  • Delivering any draft manuscripts based on this research according to the negotiated terms of the material transfer agreement

Visit the Millennium Preclinical Drug Compound Request program